Aging aggravates aortic aneurysm and dissection via miR-1204-MYLK signaling axis in mice

Ze-Long Liu1,2,3,4,5, Yan Li1,2,3,4,5, Yi-Jun Lin1,2,3,4,5

  • 1Division of Cardiac Surgery, Cardiovascular Diseases Institute, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, P.R. China.

Nature Communications
|July 16, 2024
PubMed

Insights

Aging worsens aortic aneurysm and dissection (AAD) through a miR-1204 and myosin light chain kinase (MYLK) pathway. This microRNA promotes vascular smooth muscle cell senescence, contributing to AAD development.

Area of Science:

  • Cardiovascular Biology
  • Aging Research
  • Molecular Medicine

Background:

  • The mechanisms linking aging to aortic aneurysm and dissection (AAD) are not fully understood.
  • MicroRNAs (miRNAs) are implicated in various cardiovascular diseases, but their specific role in age-related AAD requires further elucidation.

Purpose of the Study:

  • To investigate the role of microRNAs in the pathogenesis of age-related aortic aneurysm and dissection (AAD).
  • To identify specific molecular pathways involved in the exacerbation of AAD by aging.

Main Methods:

  • Screening of differentially expressed plasma microRNAs (miRNAs) in participants with and without AAD.
  • Investigating the regulatory role of miR-1204 in vascular smooth muscle cell (VSMC) senescence and phenotype.
  • Utilizing mouse models to assess the impact of miR-1204 inhibition and MYLK overexpression on AAD development.

Main Results:

  • miR-1204 was found to be significantly increased in plasma and aorta of elder patients with AAD, correlating positively with age.
  • miR-1204 promotes VSMC senescence and a senescence-associated secretory phenotype (SASP) via targeting MYLK, creating a positive feedback loop.
  • Inhibition of miR-1204 attenuated AAD development in mouse models, while MYLK overexpression reversed miR-1204-induced detrimental effects on VSMCs.

Conclusions:

  • Aging exacerbates AAD through the miR-1204-MYLK signaling axis.
  • miR-1204 plays a critical role in inducing VSMC senescence and phenotypic changes, contributing to AAD pathogenesis.
  • Targeting the miR-1204-MYLK pathway presents a potential therapeutic strategy for age-related AAD.

Related Concept Videos